谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase II study of crizotinib in patients with MET amplification and MET exon 14 deletion: Results from NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocols C1 and C2.

Niamh Coleman,Zihan Wei,David S. Hong,Edith P. Mitchell,James A. Zwiebel,Elad Sharon,Robert J. Gray,Victoria Wang,Lisa M. McShane,Larry Rubinstein,David Patton,P. Mickey Williams,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O’Dwyer,Alice Chen,Keith T. Flaherty,Stanley R. Hamilton

Journal of Clinical Oncology（2023）

引用 0|浏览53
暂无评分
关键词
crizotinib,nci-match,ecog-acrin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要